tianbing wang

Dr. tianbing wang

Anhui NO.2 Provinicial People's Hospital, Hefei, Anhui, China
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Cells
Verified
Journal Article
Open access
PDF file
YQYong Qi
Yong Qi
HWHaibo Wang
Haibo Wang
QZQikun Zhang
Qikun Zhang
ZLZhiqiang Liu
Zhiqiang Liu
TWtianbing wang
tianbing wang
WWWenyong Wu
Wenyong Wu
Currently, exosomes derived from Cancer-associated fibroblast (CAF) have reportedly been involved in regulating hepatocellular carcinoma (HCC) tumour microenvironment (TME). LIM domain and actin binding 1 (LIMA1) is an actin-binding protein that is involved in controlling the biological behaviour and progression of specific solid tumours. We aimed to determine the effect of LIMA1 and exosome-associated miR-20a-5p in HCC development. LIMA1 and miR-20a-5p expression levels were examined by real-time quantitative PCR (qRT-PCR), western blotting or immunohistochemistry (IHC). Functional experiments, including Cell Counting Kit-8 (CCK-8), 5-ethynyl-2′-deoxyuridine (EdU) assays, colony formation assays, wound healing assays, and Transwell invasion assays, were performed to investigate the effect of LIMA1 and miR-20a-5p. A dual-luciferase reporter gene assay was performed to confirm the interaction of miR-20a-5p and LIMA1. Exosomes were characterised by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blotting. We noted that LIMA1 was downregulated in human HCC tissues and cells and remarkably correlated with overall survival (OS) and recurrence-free survival (RFS). LIMA1 overexpression suppressed HCC cell proliferation and metastasis in vitro and in vivo, while LIMA1 knockdown had the opposite effects. A mechanistic investigation showed that LIMA1 inhibited the Wnt/β-catenin signalling pathway by binding to BMI1 and inducing its destabilisation. Additionally, we found that LIMA1 expression in HCC cells could be suppressed by transferring CAF-derived exosomes harbouring oncogenic miR-20a-5p. In summary, LIMA1 is a tumour suppressor that inhibits the Wnt/β-catenin signalling pathway and is downregulated by CAF-derived exosomes carrying oncogenic miR-20a-5p in HCC.

1 January 2021 in Bioengineered
Verified
Journal Article
Open access
TWtianbing wang
tianbing wang
BCBang Chen
Bang Chen
TMTao Meng
Tao Meng
ZLZhiqiang Liu
Zhiqiang Liu
WWWenyong Wu
Wenyong Wu
Tumor microenvironment (TME) is involved in the occurrence and development of hepatocellular carcinoma (HCC), and immune cells in the TME have been implicated in its progression and treatment. However, the association of genes involved in the TME with HCC prognosis remains unclear. Thus, in this study, we obtained transcriptomic and clinicopathological data of patients with HCC from The Cancer Genome Atlas to identify key genes in TME associated with HCC prognosis. Stromal and immune cell scores were calculated using the ESTIMATE method, and differentially expressed genes (DEGs) were determined. We identified 830 DEGs, which were further subjected to survival analyses and functional enrichment analysis. Next, we identified prognostic TME-associated DEGs, established a protein-protein interaction (PPI) network, and performed Cox analysis.Consequently, four key prognostic genes (CXCL5, CXCL8, IL18RAP, and TREM2) associated with TME, were identified, in which CXCL5 and IL18RAP may be potential independent prognostic factors. Age, clinical stage, N stage, and risk score were also determined as significant prognostic variables. CIBERSORT was used to predict the constitution and relative content of the immune cells, wherein M0 macrophages were the most closely related to the key genes. In conclusion, CXCL5, CXCL8, IL18RAP, and TREM2 were associated with HCC prognosis and were important for immune cell invasion into the TME. Additionally, IL18RAP expression may contribute toward favorable prognosis in patients with HCC. Consequently, these genes may serve as potential biomarkers and immunotherapeutic targets for HCC. Graphical abstract

13 March 2023 in Research Square
Verified
Preprint
Open access
PDF file
DZDi Zhang
Di Zhang
BWBijun Wang
Bijun Wang
KGKai Guo
Kai Guo
TWtianbing wang
tianbing wang
Transgelin-2 (TAGLN2) is an actin-binding protein. Its high expression also has a potential role in many malignant diseases. However, the relationship between its expression and prognosis in hepatocellular carcinoma (HCC) and its relevance to immunity remains unclear. In this study, data from the Oncomine database, TCGA database and GEPIA database were used to analyze the expression of TGALN2 in hepatocellular carcinoma. RT-PCR, qPCR, Western blot and immunohistochemistry were used to detect TAGLN2 expression in HCC tissues.TAGLN2 expression was upregulated in HCC and is a potential oncogene in HCC.Overexpression of TAGLN2 was strongly correlated with pathological stage, grade, and T-type.Cox analysis revealed that TAGLN2 was an independent risk factor for HCC prognosis. Using the Kaplan-Meier method, HCC patients with upregulated TAGLN2 expression were shown to have a poorer prognosis. Evidence was obtained using GSEA that TAGLN2 expression was closely associated with immune pathways. Subsequently, the Starbase database was used to predict the non-coding RNAs (ncRNAs) that regulate TAGLN2 overexpression, and the SNHG16–miR-22-3P axis was identified as the most valuable upstream pathway for TAGLN2 in HCC. Next, we estimated the differences in immune infiltration of 22 tumor-infiltrating immune cells (TIICs) in all HCC samples using the CIBERSORT algorithm. The results showed that the immune cells closely associated with TAGLN2 were plasma cells, CD8 T cells and M0 macrophages. TAGLN2 was positively correlated with PD-1, PD-L1 and CTLA4 using the TIMER database analysis. Our results suggest that high expression of TAGLN2, regulated by ncRNAs, is associated with poor prognosis and tumor immune cell infiltration in HCC.